Mid
A
ABTAI Stock Diagnostic Report
Abbott launches "SimpleScreen" blood test to expand cancer screening
Abbott has raised expectations for growth in its diagnostics business by launching the 'SimpleScreen' blood test for expanded cancer screening.
View Source Article ↗
AI CATALYST SCORE65 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
ABT Analysis History (Last 30 Days)